Ribonucleic Acid News and Research

RSS
T-cell responses to SARS-CoV-2 Omicron variant confer protection to vaccinated individuals

T-cell responses to SARS-CoV-2 Omicron variant confer protection to vaccinated individuals

SARS-CoV-2 Omicron variant highly resistant to vaccine-elicited and therapeutic antibodies

SARS-CoV-2 Omicron variant highly resistant to vaccine-elicited and therapeutic antibodies

Minimal nAb titers against Omicron in the elderly after 3rd dose

Minimal nAb titers against Omicron in the elderly after 3rd dose

Echinacea, a potent antiviral against SARS-CoV-2

Echinacea, a potent antiviral against SARS-CoV-2

Rapid antigen tests show lower sensitivity for Omicron than for earlier SARS-CoV-2 variants

Rapid antigen tests show lower sensitivity for Omicron than for earlier SARS-CoV-2 variants

At least 3 exposures to vaccine or virus needed for minimum protection against SARS-CoV-2 Omicron

At least 3 exposures to vaccine or virus needed for minimum protection against SARS-CoV-2 Omicron

BNT162b2 booster restores protection following waning of the 2-dose vaccine

BNT162b2 booster restores protection following waning of the 2-dose vaccine

Study demonstrates increased effectiveness of third BNT162b2 dose against SARS-CoV-2 infection and hospitalization

Study demonstrates increased effectiveness of third BNT162b2 dose against SARS-CoV-2 infection and hospitalization

New report on 1.23 million breakthrough symptomatic SARS-CoV-2 infections by vaccine

New report on 1.23 million breakthrough symptomatic SARS-CoV-2 infections by vaccine

Double-dose mRNA COVID vaccines effective among dialysis patients

Double-dose mRNA COVID vaccines effective among dialysis patients

Study suggests spike mutation makes SARS-CoV-2 Omicron milder

Study suggests spike mutation makes SARS-CoV-2 Omicron milder

Allele-specific RT-qPCR assay to identify SARS-CoV-2 Omicron variant in wastewater

Allele-specific RT-qPCR assay to identify SARS-CoV-2 Omicron variant in wastewater

Omicron has enhanced infectivity that is only weakly neutralized by vaccination or prior infection

Omicron has enhanced infectivity that is only weakly neutralized by vaccination or prior infection

T-cell response to Omicron after an mRNA COVID vaccine booster

T-cell response to Omicron after an mRNA COVID vaccine booster

Protein-based nanoparticle vaccines for protection against SARS-CoV-2

Protein-based nanoparticle vaccines for protection against SARS-CoV-2

COVID can affect sperm quality for three months

COVID can affect sperm quality for three months

How COVID vaccines protected Americans against the Delta variant

How COVID vaccines protected Americans against the Delta variant

Role of novel SARS-CoV-2-derived svRNAs and the involvement of tRF in COVID-19

Role of novel SARS-CoV-2-derived svRNAs and the involvement of tRF in COVID-19

Researchers identify novel cancer markers in patients with aggressive prostate cancer

Researchers identify novel cancer markers in patients with aggressive prostate cancer

Two-dose ChAdOx1 vaccine protection wanes after three months

Two-dose ChAdOx1 vaccine protection wanes after three months

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.